Jacobs Levy Equity Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-33,968
| Closed | -$121K | – | 1036 |
|
|
2020
Q4 | $121K | Sell |
33,968
-8,000
| -19% | -$28.5K | ﹤0.01% | 988 |
|
|
2020
Q3 | $168K | Sell |
41,968
-36,666
| -47% | -$147K | ﹤0.01% | 975 |
|
|
2020
Q2 | $214K | Buy |
78,634
+58
| +0.1% | +$158 | ﹤0.01% | 940 |
|
|
2020
Q1 | $166K | Buy |
78,576
+2,580
| +3% | +$5.45K | ﹤0.01% | 911 |
|
|
2019
Q4 | $413K | Buy |
75,996
+32,979
| +77% | +$179K | ﹤0.01% | 809 |
|
|
2019
Q3 | $129K | Sell |
43,017
-16,701
| -28% | -$50.1K | ﹤0.01% | 880 |
|
|
2019
Q2 | $223K | Buy |
+59,718
| New | +$223K | ﹤0.01% | 864 |
|
|
2019
Q1 | – | Sell |
-56,174
| Closed | -$206K | – | 972 |
|
|
2018
Q4 | $206K | Buy |
56,174
+12,400
| +28% | +$45.5K | ﹤0.01% | 873 |
|
|
2018
Q3 | $376K | Buy |
+43,774
| New | +$376K | 0.01% | 830 |
|
|
2018
Q1 | – | Sell |
-14,026
| Closed | -$145K | – | 1011 |
|
|
2017
Q4 | $145K | Buy |
+14,026
| New | +$145K | ﹤0.01% | 932 |
|